Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| UNITED THERAPEUTICS CorpUTHR · Entity 664 | Director | July 22, 2026 | July 23, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
UNITED THERAPEUTICS Corp
Report date July 22, 2026 · Filed July 23, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $527.07 · Expires 2033-07-22 | Direct | 2,380 |
Reported balance
After 2026-07-22 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-07-22 · Grant · Acquired 2,380 · Balance 2,380 F1: Annual non-employee director award. F2: Annual non-employee director awards become fully vested on the earlier to occur of (a) the one-year anniversary of the grant date; or (b) the date of the next Annual Meeting of Shareholders following the grant date. June 25, 2027 is the anticipated date of the next Annual Meeting of Shareholders. |
| Common StockSEC Table I · non-derivative | Direct | 2,410 |
Reported balance
Holding disclosure · report date 2026-07-22 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 2,410 |
Filing footnotes · ownership attribution and instrument terms
F1: Annual non-employee director award.
F2: Annual non-employee director awards become fully vested on the earlier to occur of (a) the one-year anniversary of the grant date; or (b) the date of the next Annual Meeting of Shareholders following the grant date. June 25, 2027 is the anticipated date of the next Annual Meeting of Shareholders.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 06, 2021 Filed May 10, 2021 20:31 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionCommon Stock | 2,500 | $63.90 | $159,750.00 |
DisclosureSEC source: 0001127602-21-016063 · form4.xml · nonDerivative · entry 1 PATUSKY CHRISTOPHER · CIK 0001231427 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,800 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock. Read SEC document |
| December 08, 2020 Filed Dec 9, 2020 21:31 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionShare Tracking Award · Derivative | 3,000 | $0.00 Strike: $63.90 | $0.00 |
DisclosureSEC source: 0001127602-20-030989 · form4.xml · derivative · entry 4 PATUSKY CHRISTOPHER · CIK 0001231427 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,000 Underlying: Common Stock · 3,000 shares Expires 2023-06-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock. Read SEC document |
| December 08, 2020 Filed Dec 9, 2020 21:31 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Disposition to issuerCommon Stock | 3,000 | $135.08 | $405,240.00 |
DisclosureSEC source: 0001127602-20-030989 · form4.xml · nonDerivative · entry 2 PATUSKY CHRISTOPHER · CIK 0001231427 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,300 F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock. Read SEC document |
| December 08, 2020 Filed Dec 9, 2020 21:31 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionCommon Stock | 3,000 | $63.90 | $191,700.00 |
DisclosureSEC source: 0001127602-20-030989 · form4.xml · nonDerivative · entry 1 PATUSKY CHRISTOPHER · CIK 0001231427 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,300 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock. Read SEC document |
| August 05, 2020 Filed Aug 6, 2020 22:13 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionShare Tracking Award · Derivative | 5,000 | $0.00 Strike: $54.77 | $0.00 |
DisclosureSEC source: 0001127602-20-023087 · form4.xml · derivative · entry 4 PATUSKY CHRISTOPHER · CIK 0001231427 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,000 shares Expires 2021-06-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock. Read SEC document |
| August 05, 2020 Filed Aug 6, 2020 22:13 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Disposition to issuerCommon Stock | 5,000 | $113.07 | $565,350.00 |
DisclosureSEC source: 0001127602-20-023087 · form4.xml · nonDerivative · entry 2 PATUSKY CHRISTOPHER · CIK 0001231427 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,300 F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock. Read SEC document |
| August 05, 2020 Filed Aug 6, 2020 22:13 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionCommon Stock | 5,000 | $54.77 | $273,850.00 |
DisclosureSEC source: 0001127602-20-023087 · form4.xml · nonDerivative · entry 1 PATUSKY CHRISTOPHER · CIK 0001231427 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,300 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock. Read SEC document |
| June 26, 2020 Filed Jun 30, 2020 18:03 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | GrantStock Options · Derivative | 5,160 | $0.00 Strike: $119.76 | $0.00 |
DisclosureSEC source: 0001104659-20-078805 · a4.xml · derivative · entry 5 PATUSKY CHRISTOPHER · CIK 0001231427 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,160 Underlying: Common Stock · 5,160 shares Expires not disclosed F6 · shares: Annual non-employee director grant of stock options, which are awarded and priced each year on the date of the issuer's Annual Meeting of Shareholders. F7 · derivative.exercise_date: Award becomes fully vested on the one-year anniversary of the grant date only if the reporting person attends at least 75% of the regularly scheduled meetings of the issuer's Board and his or her committee meetings from the date of grant until the date of the issuer's next annual meeting of shareholders. F8 · derivative.expiration_date: Award becomes fully vested on the one-year anniversary of the grant date only if the reporting person attends at least 75% of the regularly scheduled meetings of the issuer's Board and his or her committee meetings from the date of grant until the date of the issuer's next annual meeting of shareholders. Read SEC document |
| June 26, 2020 Filed Jun 30, 2020 18:03 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | GrantRestricted Stock Units · Derivative | 1,680 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001104659-20-078805 · a4.xml · derivative · entry 4 PATUSKY CHRISTOPHER · CIK 0001231427 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,680 Underlying: Common Stock · 1,680 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive, following vesting, one share of United Therapeutics Corporation common stock. F3 · shares: Annual non-employee director grant of restricted stock units, which are awarded each year on the date of the issuer's Annual Meeting of Shareholders. F4 · derivative.exercise_date: The restricted stock units vest on the one-year anniversary of the grant date only if the reporting person attends at least 75% of the regularly scheduled meetings of the issuer's Board and his or her committee meetings from the date of grant until the date of the issuer's next annual meeting of shareholders. Shares will be issued to the reporting person upon vesting unless the reporting person has elected to defer receipt of shares. F5 · derivative.expiration_date: The restricted stock units vest on the one-year anniversary of the grant date only if the reporting person attends at least 75% of the regularly scheduled meetings of the issuer's Board and his or her committee meetings from the date of grant until the date of the issuer's next annual meeting of shareholders. Shares will be issued to the reporting person upon vesting unless the reporting person has elected to defer receipt of shares. Read SEC document |
| June 26, 2020 Filed Jun 30, 2020 18:03 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionRestricted Stock Units · Derivative | 2,300 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001104659-20-078805 · a4.xml · derivative · entry 3 PATUSKY CHRISTOPHER · CIK 0001231427 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,300 shares Expires 2029-06-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive, following vesting, one share of United Therapeutics Corporation common stock. Read SEC document |
| June 26, 2020 Filed Jun 30, 2020 18:03 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionCommon Stock | 2,300 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-20-078805 · a4.xml · nonDerivative · entry 1 PATUSKY CHRISTOPHER · CIK 0001231427 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,300 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Shares received upon vesting of restricted stock units on June 26, 2020. Restricted stock units converted on a one-for-one basis into shares of common stock. Read SEC document |
| March 17, 2020 Filed Mar 18, 2020 20:30 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionShare Tracking Award · Derivative | 5,000 | $0.00 Strike: $54.77 | $0.00 |
DisclosureSEC source: 0001127602-20-011259 · form4.xml · derivative · entry 4 PATUSKY CHRISTOPHER · CIK 0001231427 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires 2021-06-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Read SEC document |
| March 17, 2020 Filed Mar 18, 2020 20:30 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Disposition to issuerCommon Stock | 5,000 | $80.56 | $402,800.00 |
DisclosureSEC source: 0001127602-20-011259 · form4.xml · nonDerivative · entry 2 PATUSKY CHRISTOPHER · CIK 0001231427 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Read SEC document |
| March 17, 2020 Filed Mar 18, 2020 20:30 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionCommon Stock | 5,000 | $54.77 | $273,850.00 |
DisclosureSEC source: 0001127602-20-011259 · form4.xml · nonDerivative · entry 1 PATUSKY CHRISTOPHER · CIK 0001231427 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Read SEC document |
| June 26, 2019 Filed Jun 28, 2019 20:17 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | GrantStock Options · Derivative | 6,310 | $0.00 Strike: $76.36 | $0.00 |
DisclosureSEC source: 0001127602-19-023018 · form4.xml · derivative · entry 2 PATUSKY CHRISTOPHER · CIK 0001231427 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,310 Underlying: Common Stock · 6,310 shares Expires 2029-06-26 F4 · shares: Annual non-employee director grant of stock options, which are awarded and priced each year on the date of the issuer's Annual Meeting of Shareholders. F5 · derivative.exercise_date: Award becomes fully vested on the one-year anniversary of the grant date only if the reporting person attends at least 75% of the regularly scheduled meetings of the issuer's Board and his or her committee meetings from the date of grant until the date of the issuer's next annual meeting of shareholders. Read SEC document |
| June 26, 2019 Filed Jun 28, 2019 20:17 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | GrantRestricted Stock Units · Derivative | 2,300 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-023018 · form4.xml · derivative · entry 1 PATUSKY CHRISTOPHER · CIK 0001231427 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,300 Underlying: Common Stock · 2,300 shares Expires 2029-06-26 F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive, following vesting, one share of United Therapeutics Corporation common stock. F2 · shares: Annual non-employee director grant of restricted stock units, which are awarded and priced each year on the date of the issuer's Annual Meeting of Shareholders. F3 · derivative.exercise_date: Award becomes fully vested on the one-year anniversary of the grant date only if the reporting person attends at least 75% of the regularly scheduled meetings of the issuer's Board and his or her committee meetings from the date of grant until the date of the issuer's next annual meeting of shareholders. Read SEC document |
| June 10, 2019 Filed May 3, 2023 20:30 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | PurchaseCommon Stock | 4 | $82.83 | $331.32 |
DisclosureSEC source: 0001104659-23-055524 · tm2314417-1_4seq1.xml · nonDerivative · entry 9 PATUSKY CHRISTOPHER · CIK 0001231427 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,684 F1 · balance_after: This Form 4 reflects the reporting person's holdings as of May 3, 2023, the date of this Form 4. Read SEC document |
| March 20, 2019 Filed Mar 22, 2019 20:16 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionShare Tracking Award · Derivative | 5,000 | $0.00 Strike: $54.77 | $0.00 |
DisclosureSEC source: 0001127602-19-012919 · form4.xml · derivative · entry 4 PATUSKY CHRISTOPHER · CIK 0001231427 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 5,000 shares Expires 2021-06-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 20, 2019 Filed Mar 22, 2019 20:16 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Disposition to issuerCommon Stock | 5,000 | $121.24 | $606,200.00 |
DisclosureSEC source: 0001127602-19-012919 · form4.xml · nonDerivative · entry 2 PATUSKY CHRISTOPHER · CIK 0001231427 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Read SEC document |
| March 20, 2019 Filed Mar 22, 2019 20:16 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionCommon Stock | 5,000 | $54.77 | $273,850.00 |
DisclosureSEC source: 0001127602-19-012919 · form4.xml · nonDerivative · entry 1 PATUSKY CHRISTOPHER · CIK 0001231427 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 07, 2019 Filed Mar 8, 2019 21:02 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | SaleCommon Stock | 3,370 | $110.75 | $373,227.50 |
DisclosureSEC source: 0001127602-19-010575 · form4.xml · nonDerivative · entry 1 PATUSKY CHRISTOPHER · CIK 0001231427 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · price: This transaction was executed in multiple trades at prices ranging from $110.66 to $110.815. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| December 28, 2018 Filed May 3, 2023 20:30 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | SaleCommon Stock | 4 | $105.11 | $420.44 |
DisclosureSEC source: 0001104659-23-055524 · tm2314417-1_4seq1.xml · nonDerivative · entry 8 PATUSKY CHRISTOPHER · CIK 0001231427 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,680 Read SEC document |
| July 06, 2018 Filed Jul 9, 2018 20:02 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionShare Tracking Award · Derivative | 3,500 | $0.00 Strike: $51.77 | $0.00 |
DisclosureSEC source: 0001127602-18-022973 · form4.xml · derivative · entry 4 PATUSKY CHRISTOPHER · CIK 0001231427 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,500 shares Expires 2020-06-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Read SEC document |
| July 06, 2018 Filed Jul 9, 2018 20:02 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Disposition to issuerCommon Stock | 3,500 | $120.29 | $421,015.00 |
DisclosureSEC source: 0001127602-18-022973 · form4.xml · nonDerivative · entry 2 PATUSKY CHRISTOPHER · CIK 0001231427 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,370 F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Read SEC document |
| July 06, 2018 Filed Jul 9, 2018 20:02 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionCommon Stock | 3,500 | $51.77 | $181,195.00 |
DisclosureSEC source: 0001127602-18-022973 · form4.xml · nonDerivative · entry 1 PATUSKY CHRISTOPHER · CIK 0001231427 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,870 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Read SEC document |
| June 28, 2018 Filed Jun 28, 2018 23:11 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionRestricted Stock Units · Derivative | 1,620 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-021986 · form4.xml · derivative · entry 4 PATUSKY CHRISTOPHER · CIK 0001231427 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,620 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each restricted stock unit represents the right to receive, following vesting, one share of United Therapeutics Corporation common stock. F5 · derivative.exercise_date: The restricted stock units vest on the one-year anniversary of the grant date only if the reporting person attends at least 75% of the regularly scheduled meetings of the issuer's Board and his or her committee meetings from the date of grant until the date of the issuer's next annual meeting of shareholders. Shares will be issued to the reporting person upon vesting unless the reporting person has elected to defer receipt of shares. F5 · derivative.expiration_date: The restricted stock units vest on the one-year anniversary of the grant date only if the reporting person attends at least 75% of the regularly scheduled meetings of the issuer's Board and his or her committee meetings from the date of grant until the date of the issuer's next annual meeting of shareholders. Shares will be issued to the reporting person upon vesting unless the reporting person has elected to defer receipt of shares. Read SEC document |
| June 28, 2018 Filed Jun 28, 2018 23:11 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionCommon Stock | 1,620 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-021986 · form4.xml · nonDerivative · entry 1 PATUSKY CHRISTOPHER · CIK 0001231427 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,370 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Shares received upon vesting of restricted stock units on June 28, 2018. Restricted stock units converted on a one-for-one basis into shares of common stock. Read SEC document |
| June 26, 2018 Filed Jun 28, 2018 23:11 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | GrantStock Options · Derivative | 9,240 | $0.00 Strike: $112.14 | $0.00 |
DisclosureSEC source: 0001127602-18-021986 · form4.xml · derivative · entry 3 PATUSKY CHRISTOPHER · CIK 0001231427 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,240 Underlying: Common Stock · 9,240 shares Expires 2028-06-26 F2 · shares: Annual non-employee director grant of stock options, which are awarded and priced each year on the date of the issuer's Annual Meeting of Shareholders. F3 · derivative.exercise_date: Award becomes fully vested on the one-year anniversary of the grant date only if the reporting person attends at least 75% of the regularly scheduled meetings of the issuer's Board and his or her committee meetings from the date of grant until the date of the issuer's next annual meeting of shareholders. Read SEC document |
| May 21, 2018 Filed May 3, 2023 20:30 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | SaleCommon Stock | 2 | $104.12 | $208.24 |
DisclosureSEC source: 0001104659-23-055524 · tm2314417-1_4seq1.xml · nonDerivative · entry 7 PATUSKY CHRISTOPHER · CIK 0001231427 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,684 Read SEC document |
| April 20, 2018 Filed May 3, 2023 20:30 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | PurchaseCommon Stock | 6 | $114.06 | $684.36 |
DisclosureSEC source: 0001104659-23-055524 · tm2314417-1_4seq1.xml · nonDerivative · entry 6 PATUSKY CHRISTOPHER · CIK 0001231427 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,686 Read SEC document |
| March 20, 2018 Filed May 3, 2023 20:30 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | SaleCommon Stock | 5 | $107.71 | $538.55 |
DisclosureSEC source: 0001104659-23-055524 · tm2314417-1_4seq1.xml · nonDerivative · entry 5 PATUSKY CHRISTOPHER · CIK 0001231427 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,680 Read SEC document |
| January 16, 2018 Filed Jan 18, 2018 13:41 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionShare Tracking Award · Derivative | 4,000 | $0.00 Strike: $51.77 | $0.00 |
DisclosureSEC source: 0001127602-18-002000 · form4.xml · derivative · entry 3 PATUSKY CHRISTOPHER · CIK 0001231427 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,500 Underlying: Common Stock · 4,000 shares Expires 2020-06-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Read SEC document |
| January 16, 2018 Filed Jan 18, 2018 13:41 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Disposition to issuerCommon Stock | 4,000 | $135.12 | $540,480.00 |
DisclosureSEC source: 0001127602-18-002000 · form4.xml · nonDerivative · entry 2 PATUSKY CHRISTOPHER · CIK 0001231427 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,750 F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Read SEC document |
| January 16, 2018 Filed Jan 18, 2018 13:41 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionCommon Stock | 4,000 | $51.77 | $207,080.00 |
DisclosureSEC source: 0001127602-18-002000 · form4.xml · nonDerivative · entry 1 PATUSKY CHRISTOPHER · CIK 0001231427 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,750 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Read SEC document |
| November 20, 2017 Filed May 3, 2023 20:30 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | PurchaseCommon Stock | 5 | $126.20 | $631.00 |
DisclosureSEC source: 0001104659-23-055524 · tm2314417-1_4seq1.xml · nonDerivative · entry 4 PATUSKY CHRISTOPHER · CIK 0001231427 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,685 Read SEC document |
| October 20, 2017 Filed May 3, 2023 20:30 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | SaleCommon Stock | 6 | $121.01 | $726.06 |
DisclosureSEC source: 0001104659-23-055524 · tm2314417-1_4seq1.xml · nonDerivative · entry 3 PATUSKY CHRISTOPHER · CIK 0001231427 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,680 Read SEC document |
| July 28, 2017 Filed May 3, 2023 20:30 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | PurchaseCommon Stock | 3 | $128.35 | $385.05 |
DisclosureSEC source: 0001104659-23-055524 · tm2314417-1_4seq1.xml · nonDerivative · entry 2 PATUSKY CHRISTOPHER · CIK 0001231427 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,686 Read SEC document |
| July 17, 2017 Filed May 3, 2023 20:30 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | PurchaseCommon Stock | 3 | $130.24 | $390.72 |
DisclosureSEC source: 0001104659-23-055524 · tm2314417-1_4seq1.xml · nonDerivative · entry 1 PATUSKY CHRISTOPHER · CIK 0001231427 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,683 Read SEC document |
| June 28, 2017 Filed Jun 30, 2017 20:24 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | GrantStock Options · Derivative | 4,210 | $0.00 Strike: $132.30 | $0.00 |
DisclosureSEC source: 0001127602-17-022462 · form4.xml · derivative · entry 2 PATUSKY CHRISTOPHER · CIK 0001231427 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,210 Underlying: Common Stock · 4,210 shares Expires 2027-06-28 F2 · shares: Annual non-employee director grant of restricted stock units and/or stock options, which are awarded and priced each year on the date of the issuer's Annual Meeting of Shareholders. F4 · derivative.exercise_date: Award becomes fully vested on the one-year anniversary of the grant date only if the reporting person attends at least 75% of the regularly scheduled meetings of the issuer's Board and his or her committee meetings from the date of grant until the date of the issuer's next annual meeting of shareholders. Read SEC document |
| June 28, 2017 Filed Jun 30, 2017 20:24 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | GrantRestricted Stock Units · Derivative | 1,620 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-022462 · form4.xml · derivative · entry 1 PATUSKY CHRISTOPHER · CIK 0001231427 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,620 Underlying: Common Stock · 1,620 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive, following vesting, one share of United Therapeutics Corporation common stock. F2 · shares: Annual non-employee director grant of restricted stock units and/or stock options, which are awarded and priced each year on the date of the issuer's Annual Meeting of Shareholders. F3 · derivative.exercise_date: The restricted stock units vest on the one-year anniversary of the grant date only if the reporting person attends at least 75% of the regularly scheduled meetings of the issuer's Board and his or her committee meetings from the date of grant until the date of the issuer's next annual meeting of shareholders. Shares will be issued to the reporting person upon vesting unless the reporting person has elected to defer receipt of shares. F3 · derivative.expiration_date: The restricted stock units vest on the one-year anniversary of the grant date only if the reporting person attends at least 75% of the regularly scheduled meetings of the issuer's Board and his or her committee meetings from the date of grant until the date of the issuer's next annual meeting of shareholders. Shares will be issued to the reporting person upon vesting unless the reporting person has elected to defer receipt of shares. Read SEC document |
| June 21, 2017 Filed Jun 22, 2017 20:10 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionRestricted Stock Units · Derivative | 1,750 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-022041 · form4.xml · derivative · entry 3 PATUSKY CHRISTOPHER · CIK 0001231427 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,750 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Restricted stock units were granted on June 21, 2016, and vested on June 21, 2017. The entire number of restricted stock units converted into shares of common stock upon vesting. F2 · derivative.exercise_date: Restricted stock units were granted on June 21, 2016, and vested on June 21, 2017. The entire number of restricted stock units converted into shares of common stock upon vesting. F2 · derivative.expiration_date: Restricted stock units were granted on June 21, 2016, and vested on June 21, 2017. The entire number of restricted stock units converted into shares of common stock upon vesting. Read SEC document |
| June 21, 2017 Filed Jun 22, 2017 20:10 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionCommon Stock | 1,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-022041 · form4.xml · nonDerivative · entry 1 PATUSKY CHRISTOPHER · CIK 0001231427 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,750 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Shares received upon vesting of restricted stock units on June 21, 2017. Restricted stock units converted on a one-for-one basis into shares of common stock. Read SEC document |
| March 09, 2017 Filed Mar 13, 2017 13:25 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionShare Tracking Award · Derivative | 3,000 | $0.00 Strike: $48.11 | $0.00 |
DisclosureSEC source: 0001127602-17-011331 · form4.xml · derivative · entry 3 PATUSKY CHRISTOPHER · CIK 0001231427 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,000 shares Expires 2022-06-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Read SEC document |
| March 09, 2017 Filed Mar 13, 2017 13:25 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Disposition to issuerCommon Stock | 3,000 | $146.44 | $439,320.00 |
DisclosureSEC source: 0001127602-17-011331 · form4.xml · nonDerivative · entry 2 PATUSKY CHRISTOPHER · CIK 0001231427 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Read SEC document |
| March 09, 2017 Filed Mar 13, 2017 13:25 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionCommon Stock | 3,000 | $48.11 | $144,330.00 |
DisclosureSEC source: 0001127602-17-011331 · form4.xml · nonDerivative · entry 1 PATUSKY CHRISTOPHER · CIK 0001231427 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Read SEC document |
| January 12, 2017 Filed Jan 12, 2017 21:32 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionStock Options · Derivative | 5,000 | $0.00 Strike: $30.75 | $0.00 |
DisclosureSEC source: 0001127602-17-001612 · form4.xml · derivative · entry 4 PATUSKY CHRISTOPHER · CIK 0001231427 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,000 shares Expires 2018-04-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise of stock options and corresponding sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Read SEC document |
| January 12, 2017 Filed Jan 12, 2017 21:32 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | SaleCommon Stock | 5,000 | $141.99 | $709,968.50 |
DisclosureSEC source: 0001127602-17-001612 · form4.xml · nonDerivative · entry 2 PATUSKY CHRISTOPHER · CIK 0001231427 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: This exercise of stock options and corresponding sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. F3 · price: This transaction was executed in multiple trades at prices ranging from $141.86 to $142.67. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| January 12, 2017 Filed Jan 12, 2017 21:32 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionCommon Stock | 5,000 | $30.75 | $153,750.00 |
DisclosureSEC source: 0001127602-17-001612 · form4.xml · nonDerivative · entry 1 PATUSKY CHRISTOPHER · CIK 0001231427 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise of stock options and corresponding sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. F2 · price: Exercise price and number of shares/awards has been adjusted to reflect the issuer's two-for-one stock split on September 22, 2009. Read SEC document |
| November 10, 2016 Filed Nov 14, 2016 21:30 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionStock Options · Derivative | 5,000 | $0.00 Strike: $30.75 | $0.00 |
DisclosureSEC source: 0001127602-16-066948 · form4.xml · derivative · entry 6 PATUSKY CHRISTOPHER · CIK 0001231427 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires 2018-04-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Exercise price and number of shares/awards has been adjusted to reflect the issuer's two-for-one stock split on September 22, 2009. F1 · kind: This exercise of stock options and corresponding sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Read SEC document |
| November 10, 2016 Filed Nov 14, 2016 21:30 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | SaleCommon Stock | 2,295 | $130.96 | $300,543.79 |
DisclosureSEC source: 0001127602-16-066948 · form4.xml · nonDerivative · entry 4 PATUSKY CHRISTOPHER · CIK 0001231427 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: This exercise of stock options and corresponding sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. F5 · price: This transaction was executed in multiple trades at prices ranging from $130.75 to $131.02. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.